Skip to content

13F-HR filed by Defilade Capital Management, L.P.

Defilade Capital Management, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 20:30:58 UTC, with 30 holding rows worth $598,799,890.

Accession
0002088557-26-000010
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 30 entries on the cover page, a total value of $598,799,890 stated on the cover page (in dollars after the unit check, H1), rows summing to $598,799,890 with VALUE read as dollars as filed, 13F file number 028-26338. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Pfizer Inc.717081103COM1,524,999$43,492,971dollars as filed
Eli Lilly and Company532457108COM34,774$40,236,300dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM601,922$36,115,320dollars as filed
Gilead Sciences,Inc.375558103COM226,572$33,770,557dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock175,371$32,336,659dollars as filed
Amgen Inc.031162100COM74,079$31,225,039dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,272,497$30,610,535dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*128,858$29,357,718dollars as filed
Intuitive Surgical,Inc.46120E602COM71,860$29,220,432dollars as filed
Stryker Corporation863667101COM81,524$22,450,894dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK652,377$21,065,253dollars as filed
COGENT BIOSCIENCES INC19240Q201COM631,645$20,225,273dollars as filed
VEEVA SYS INC CL A COM922475108Stock69,141$19,736,298dollars as filed
ROYALTY PHARMA PLCG7709Q104SHS CLASS A332,200$19,387,192dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM570,318$18,963,074dollars as filed
Thermo Fisher Scientific Inc.883556102COM26,469$17,867,898dollars as filed
OCULAR THERAPEUTIX INC67576A100COM2,275,512$17,453,177dollars as filed
LARIMAR THERAPEUTICS INC517125100COM4,934,439$15,765,533dollars as filed
Boston Scientific Corporation101137107COM350,778$15,311,460dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock71,186$14,611,638dollars as filed
SOLVENTUM CORP COM SHS83444M101Stock165,673$14,604,075dollars as filed
ENVISTA HOLDINGS CORPORATION29415F104COM534,430$12,543,072dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM1,440,157$12,442,956dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK1,430,573$11,816,533dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM3,525,338$8,919,105dollars as filed
ICU MED INC44930G107COM54,435$8,737,362dollars as filed
ENOVIS CORPORATION194014502COM399,651$7,301,624dollars as filed
PACS GROUP INC69380Q107COM SHS164,984$6,855,085dollars as filed
BLACK DIAMOND THERAPEUTICS I09203E105COM1,770,948$3,338,237dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN7,558,756$3,038,620dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002088557-26-000010this filing2026-11-16